Literature DB >> 23640659

Strategies to improve adverse drug reaction reporting: a critical and systematic review.

Cristian Gonzalez-Gonzalez1, Elena Lopez-Gonzalez, Maria T Herdeiro, Adolfo Figueiras.   

Abstract

BACKGROUND: Underreporting is the major limitation of a voluntary adverse drug reaction (ADR) reporting system. Many studies have assessed the effectiveness of different interventions designed to reduce underreporting.
OBJECTIVE: We aimed to conduct a critical review of papers that assessed the effectiveness of different strategies to increase ADR reporting, regardless of the health professionals or patients included. DATA SOURCES: Scientific papers were selected after a search of the MEDLINE-PubMed and EMBASE scientific databases up to 7 December 2010. STUDY SELECTION: We included papers in English, French or Spanish that analysed an intervention aimed at increasing the number of reported ADRs, and quantify the results of the intervention in terms of number of reports. DATA EXTRACTION: The abstracts retrieved in both computerized searches were reviewed independently by two of the authors. Initially selected papers were thoroughly read to evaluate if they met inclusion and exclusion criteria. Data in finally selected papers were independently extracted by both authors and set in pre-designed tables. A third author took the final decision in case of disagreement. For each study, we analysed study design, type of intervention, assessment period, and results of the intervention.
RESULTS: Of the 4,221 papers located that fulfilled the search criteria, 43 met the selection criteria. With the exception of one study, the interventions assessed were deemed to be effective. The vast majority of papers displayed methodological and formal limitations that lowered the grade of evidence. Multiple interventions seem to have had more impact than did single interventions. There were very few cases in which interventions were designed on the basis of inappropriate attitudes and mistaken beliefs about ADRs.
CONCLUSIONS: In general, there is a need for studies of better methodological quality in this topic, so that more evidence of the effectiveness of the respective strategies can be collected for the purpose of improving ADR reporting by health professionals. It is probable that multiple interventions cause greater increases in the ADR reporting rates than single.

Entities:  

Mesh:

Year:  2013        PMID: 23640659     DOI: 10.1007/s40264-013-0058-2

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  69 in total

1.  A novel scheme for the reporting of adverse drug reactions.

Authors:  A Clarkson; E Ingleby; I Choonara; P Bryan; P Arlett
Journal:  Arch Dis Child       Date:  2001-04       Impact factor: 3.791

2.  Adverse drug reaction reporting system: developing a well-monitored program.

Authors:  D J Kilarski; B Ziegler; J Coarse; C Buchanan
Journal:  Hosp Formul       Date:  1986-09

3.  Can a multidisciplinary initiative to increase adverse drug reaction reporting work?

Authors:  Kristen A Perkerson; Robert A Quercia; Monica Goldman; Ginger Goddu; Craig I Coleman
Journal:  Conn Med       Date:  2004-05

4.  Toward improved adverse event/suspected adverse drug reaction reporting.

Authors:  Robert Gross; Brian L Strom
Journal:  Pharmacoepidemiol Drug Saf       Date:  2003-03       Impact factor: 2.890

5.  Program for improving adverse drug reaction reporting.

Authors:  C A Chatas; B E Vinson
Journal:  Am J Hosp Pharm       Date:  1990-01

6.  Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project.

Authors:  H D Scott; A Thacher-Renshaw; S E Rosenbaum; W J Waters; M Green; L G Andrews; G A Faich
Journal:  JAMA       Date:  1990-04-04       Impact factor: 56.272

7.  Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions.

Authors:  G W Gilroy; M J Scollins; C A Gay; D J Harry; D F Giannuzzi
Journal:  Am J Hosp Pharm       Date:  1990-06

8.  Adverse drug reactions: a pharmacist-based monitoring system.

Authors:  P Gardner; L J Watson
Journal:  Clin Pharmacol Ther       Date:  1970 Nov-Dec       Impact factor: 6.875

9.  Effect of an intervention on the features of adverse drug reactions spontaneously reported in a hospital.

Authors:  Gloria Cereza; Antonia Agustí; Consuelo Pedrós; Antonio Vallano; Cristina Aguilera; Immaculada Danés; Xavier Vidal; Josep Maria Arnau
Journal:  Eur J Clin Pharmacol       Date:  2010-06-16       Impact factor: 2.953

10.  Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study.

Authors:  K J Patel; M S Kedia; D Bajpai; S S Mehta; N A Kshirsagar; N J Gogtay
Journal:  BMC Clin Pharmacol       Date:  2007-07-28
View more
  39 in total

1.  Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial.

Authors:  Elena Lopez-Gonzalez; Maria T Herdeiro; María Piñeiro-Lamas; Adolfo Figueiras
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

2.  Resident and nurse reports of potential adverse drug reactions.

Authors:  Tinne Dilles; Bart Van Rompaey; Peter Van Bogaert; Monique M Elseviers
Journal:  Eur J Clin Pharmacol       Date:  2015-04-24       Impact factor: 2.953

3.  Effect of Educational Interventions on Adverse Drug Reaction Reporting in a Cancer Institute in Japan: A Questionnaire Study.

Authors:  Masami Tsuchiya; Akihisa Esashi; Taku Obara; Kyoko Inooka; Nariyasu Mano; Chizuko Takamura
Journal:  Hosp Pharm       Date:  2018-04-13

Review 4.  Pharmacists in pharmacovigilance: can increased diagnostic opportunity in community settings translate to better vigilance?

Authors:  Paul Rutter; David Brown; Justine Howard; Christine Randall
Journal:  Drug Saf       Date:  2014-07       Impact factor: 5.606

5.  Pharmacovigilance: empowering healthcare professionals and patients.

Authors:  Stephane Steurbaut; Yolande Hanssens
Journal:  Int J Clin Pharm       Date:  2014-09-05

6.  Discordance between patient and clinician reports of adverse reactions to MDR-TB treatment.

Authors:  A M Kelly; B Smith; Z Luo; B Given; T Wehrwein; I Master; J E Farley
Journal:  Int J Tuberc Lung Dis       Date:  2016-04       Impact factor: 2.373

7.  Barriers to the success of an electronic pharmacovigilance reporting system in Kenya: an evaluation three years post implementation.

Authors:  Oscar O Agoro; Sarah W Kibira; Jenny V Freeman; Hamish S F Fraser
Journal:  J Am Med Inform Assoc       Date:  2018-06-01       Impact factor: 4.497

8.  Pharmacovigilance in developing countries (part II): a path forward.

Authors:  Shaimaa Elshafie; Anne Marie Roberti; Iman Zaghloul
Journal:  Int J Clin Pharm       Date:  2018-08

9.  A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.

Authors:  Olga Morales Ríos; Luis Jasso Gutiérrez; Juan O Talavera; Martha María Téllez-Rojo; Víctor Olivar López; Juan Garduño Espinosa; Onofre Muñoz Hernández
Journal:  Int J Clin Pharm       Date:  2016-02

10.  Adverse drug reaction reporting in a large tertiary hospital in Saudi Arabia: results of an incentive strategy.

Authors:  Sheraz Ali; Oluwaseun Egunsola; Dalal Salem Al-Dossari; Ibrahim Abdulaziz Al-Zaagi
Journal:  Ther Adv Drug Saf       Date:  2018-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.